In vivo assessment of bacteriotherapy on acetaminophen-induced uremic rats

Journal of Nephrology

Volumn 26, Issue 1, 2013, Pages 228-236

  Mandal, Arpita ^a   Das, Koushik ^a   Roy, Suchismita ^a   Mondal, Keshab Ch ^b   Nandi, Dilip Kumar ^a,c  

^a Raja Narendra Lal Khan Women's College   (India)

^b VIDYASAGAR UNIVERSITY   (India)

^c Dialysis Unit   (India)

Author keywords

Acetaminophen; Enteric dialysis; Sporosarcina pasteurii; Uremia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CREATININE; HEMOGLOBIN; MALONALDEHYDE; NITROGEN; PROBIOTIC AGENT; SUPEROXIDE DISMUTASE; UREA; UREASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALANINE AMINOTRANSFERASE KIDNEY LEVEL; ALANINE AMINOTRANSFERASE LIVER LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD LEVEL; BLOOD SAMPLING; BODY WEIGHT; CATALASE BLOOD LEVEL; CATALASE KIDNEY LEVEL; CATALASE LIVER LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; DRUG EFFECT; ENZYME ACTIVITY; ENZYME SYNTHESIS; ERYTHROCYTE COUNT; FECES ANALYSIS; IN VIVO STUDY; MALE; MALONDIALDEHYDE BLOOD LEVEL; MALONDIALDEHYDE KIDNEY LEVEL; MALONDIALDEHYDE LIVER LEVEL; MICROBIAL ACTIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; RAT; SPOROSARCINA PASTEURII; SUPEROXIDE DISMUTASE BLOOD LEVEL; SUPEROXIDE DISMUTASE KIDNEY LEVEL; SUPEROXIDE DISMUTASE LIVER LEVEL; TISSUE LEVEL; UREA NITROGEN BLOOD LEVEL; UREMIA;

ACETAMINOPHEN; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL THERAPY; BLOOD UREA NITROGEN; CATALASE; FECES; KIDNEY; LIVER; MALE; MALONDIALDEHYDE; RATS; RATS, WISTAR; SPOROSARCINA; SUPEROXIDE DISMUTASE; UREMIA;

EID: 84877093516     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000129     Document Type: Article

References (27)

1. Ayodele OE, Alebiosu CO. Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis. 2010; 17(3):215-224.
2. Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM. Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant. 2005;20(8):1638-1642.
3. Nelson SD. Mechanisms of the formation and disposition of reactive metabolites that can cause acute liver injury. Drug Metab Rev. 1995;27(1-2):147-177.
4. Jones AF, Vale JA. Paracetamol poisoning and the kidney. J Clin Pharm Ther. 1993;18(1):5-8.
5. Hart SG, Beierschmitt WP, Wyand DS, Khairallah EA, Cohen SD. Acetaminophen nephrotoxicity in CD-1 mice: Part I: evidence of a role for in situ activation in selective covalent binding and toxicity. Toxicol Appl Pharmacol. 1994;126(2): 267-275.
6. Sparks RE. Review of gastrointestinal perfusion in the treatment of uremia. Clin Nephrol. 1979;11(2):81-85.
7. Hida M, Aiba Y, Sawamura S, Suzuki N, Satoh T, Koga Y. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron. 1996;74(2):349-355.
8. Patel BG, Zelenaia OZ, Dhree RS, Natarajan R, Friedman EA. Oral bacteriotherapy effectively reduces severity of azotemia in 5/6th nephrectomized rats [abstract]. J Am Soc Nephrol. 2003;14:765A (SU-PO1042).
9. Dunn SR, Marczely J, Ranganathan P, Michael LS, Friedman EA. Probiotics extend survival in untreated 5/6th nephrectomized rats: possible use for probiotics as an adjunct in chronic renal failure (CRF) [abstract]. J Am Soc Nephrol. 2003;14: 765A (SU-PO1043).
10. Ranganathan N, Patel B, Ranganathan P, et al. Probiotic amelioration of azotemia in 5/6th nephrectomized Sprague-Dawley rats. ScientificWorldJournal. 2005;5:652-660.
11. Olert ED, Cross BM, McWilliam AA. Guide to care and use of experimental animals. In: Olert ED, McWilliam BM, eds. Canadian Council on Animal Care. Vol. 1; 2nd ed. Ottawa: US National Institutes of Health;1993:40-93.
12. Ranganathan N, Patel BG, Ranganathan P, et al. In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease. ASAIO J. 2006;52(1):70-79.
13. Burtis CA, Ashwood ER. Tietz textbook of clinical chemistry. 3rd ed. Philadelphia, PA: WB Saunders; 1999:809-861.
14. Sabbagh M, Rick W, Schneider S. A kinetic method for the direct determination of creatinine in serum with 3,5-dinitrobenzoic acid without deproteinization. J Clin Chem Clin Biochem. 1988;26(1):15-24.
15. Beers RF Jr, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952;195(1):133-140.
16. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47(3): 469-474.
17. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351-358.
18. Goel BK. Routine biochemical test. In: Mukherjee KL, ed. Medical laboratory technology. Vol. 3. New Delhi: Tata Mc-Graw-Hill; 1988:985-1079.
19. Bennett WM, Parker RA, Elliott WC, Gilbert DN, Houghton DC. Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity. J Infect Dis. 1982;145(3):370-373.
20. Guyton AC. Red blood cells, anemia, and polycythemia. In: Textbook of Medical Physiology. 8th ed. Philadelphia: W.B. Saunders; 1991:56-64.
21. Mayne PD. The kidneys and renal calculi. In: Clinical chemistry in diagnosis and treatment. 6th ed. London: Edward Arnold; 1994:2-24.
22. Ali BH, Ben Ismail TH, Basheer AA. Sex related differences in the susceptibility of rat to gentamicin nephrotoxicity: influence of gonadectomy and hormonal replacement therapy. Indian J Pharmacol. 2001;33:369-373.
23. Somani SM, Husain K, Whitworth C, Trammell GL, Malafa M, Rybak LP. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol. 2000;86(5):234-241.
24. Abdel-Zaher OA, Abdel-Rahman MM, Hafez MM, Omran FM. Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage. Toxicology. 2007;243(1-2):124-134.
25. Pande M, Flora SJ. Lead induced oxidative damage and its response to combined administration of alpha-lipoic acid and succimers in rats. Toxicology. 2002;177(2-3):187-196.
26. Manov I, Hirsh M, Ianccu TC. Acetaminophen hepatotoxicity and mechanisms of its protection by N-acetylcysteine: a study of Hep3B cells. Exp Toxicol Pathol. 2002;53(6):489-500.
27. Corcoran GB, Racz WJ, Smith CV, Mitchell JR. Effects of N-acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice. J Pharmacol Exp Ther. 1985;232(3): 864-872.